Overexpression of alpha-1-antitrypsin (SERPINA1) promotes tumor progression in colorectal [30] and gastric [31] cancer, and its high level in plasma was observed in lung and prostate cancer patients [32]. Here, SERPINA1 is linked to prostate carcinoma.